Persistent high-risk HPV is an established causal route for HPV-associated cervical cancer. Vaccination and oncogene-dependency evidence support different causal steps, while rare rigorously classified HPV-independent tumours bound a universal formulation.
This dated addendum adds selected evidence and tests that could resolve the remaining questions. It does not regrade the archived review.
Each question identifies a limit in the checked evidence. A missing search result alone does not establish a gap in the entire field.
Competing explanation: False-negative viral testing or tumour-site misclassification may mimic independence.
Discriminating test: Multicentre central pathology with orthogonal DNA/RNA viral testing, adequate tissue controls and confirmed primary site; report histological strata.
Competing explanation: Host immunity, smoking, viral type or duration may modify progression rather than infection being sufficient.
Discriminating test: Prospective type-resolved cohorts with serial infection and lesion assessments, immune/cofactor measures and predefined interaction models.
Competing explanation: Efficient cell-line editing may not reproduce delivery, specificity or escape in heterogeneous tumours.
Discriminating test: Disease-relevant target-engagement models followed by appropriate clinical trials; measure delivery, off-target effects, resistance and tumour outcomes.
Competing explanation: Screening access, vaccine uptake and age at vaccination can alter observed population effects.
Discriminating test: Longitudinal registry follow-up with screening histories and coverage; triangulate independent populations and preserve precursor versus invasive-cancer endpoints.
Electronic publication dates are used where recorded, with issue years shown separately. This is a selected chronology, not a claim of scientific priority or independent replication for every entry.
Improved testing found HPV in nearly all adequately assessed cervical cancers in the series.
What it cannot establish: Historical case mix and detection do not settle every subsequently defined histological exception.
Vaccination reduced vaccine-type high-grade lesions in previously uninfected women.
What it cannot establish: A precursor endpoint and prophylactic population differ from treatment of established cancer.
Suppressing E7 caused regression of dysplasia and established tumours.
What it cannot establish: Model-specific oncogene maintenance does not demonstrate clinical delivery or cure.
Persistent carcinogenic HPV predicted elevated long-term cervical-cancer risk.
What it cannot establish: Most infections do not progress; persistence and host cofactors matter.
E6/E7 disruption produced cell-cycle arrest and cell death.
What it cannot establish: Cell-line targeting is not an in vivo clinical efficacy result.
Vaccination was associated with substantially lower invasive-cancer risk.
What it cannot establish: Nonrandomized vaccine uptake and cohort factors require consideration.
Younger vaccine-offer cohorts had large reductions in cervical cancer and CIN3.
What it cannot establish: Population programme effects and screening changes need separate attribution.
Rare HPV-independent squamous carcinomas were identified.
What it cannot establish: Rare exceptions require adequate sampling, site confirmation and orthogonal HPV tests.
HPV-independent squamous tumours had distinct molecular and clinical features.
What it cannot establish: A small series cannot estimate population prevalence or treatment response reliably.
Case-specific Consensus records assisted gap discovery, chronology and targeted paper questions. Shared template wording about an amyloid-specific Deep follow-up is not evidence of a Deep run for this topic; the dated source records establish the actual use and access limits. Primary identifiers, selected abstract passages, correction notices and available primary-body passages were cross-checked. Generated absence cells, duplicate milestones and unsupported access claims were rejected.
Primary abstract/metadata checked. Additional Consensus full-text details remain provider-reported because a separately readable body was unavailable in this update.
This focused addendum does not establish 50–70 complete primary Methods/Results examinations per review. Baseline reading receipts and scores retain their original scope.
Selected full-text checks: 0; abstract checks: 9; metadata-only anchors: 0. Complete-paper examinations credited in this update: 0.
New enrichment: HSEF v5.3 causal distinctions. Archived scorecard schema: 5.4; retained as recorded.
The initial broad browser response retrieved irrelevant records. A focused follow-up still missed some mechanistic and exception papers; those details were checked in primary records rather than inferred absent.
PMID 10451482 · DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
PMID 17494925 · DOI 10.1056/NEJMoa061741
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
PMID 19435895 · DOI 10.1158/0008-5472.CAN-09-0023
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
PMID 21900119 · DOI 10.1093/jnci/djr283
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
PMID 25100830 · DOI 10.1128/JVI.01879-14
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
PMID 32997908 · DOI 10.1056/NEJMoa1917338
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
PMID 34741816 · DOI 10.1016/S0140-6736(21)02178-4
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
PMID 37702216 · DOI 10.1097/PAS.0000000000002122
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
PMID 40347270 · DOI 10.1007/s00428-025-04113-6
Selected abstract passages checked. Primary record and selected abstract passages checked; no complete-paper appraisal credited.
Read the dated addendum · Video script and storyboard insert · References (RIS) · References (BibTeX)